Second-quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 millionAs of June 30, 2025, more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, ...

Madrigal Pharmaceuticals Inc. MDGL) on Tuesday reported a loss of $42.3 million in its second quarter.

With U.S. stock markets set to open in two hours, BWX Technologies Inc. (BWXT) was up 13.7% in pre-market trading, and Madrigal Pharmaceuticals Inc. (MDGL) was up 11.5%.

Akari knocked out Petro Gazz, 32-30, 25-22, 25-19, to move on to the PVL on Tour quarterfinals on Tuesday at Philsports Arena ...

Chen Tagaod torched Petro Gazz from the service line as Akari completed a hard-fought 32-30, 25-22, 25-19 win in the 2025 ...

Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track Preclinical ...